{"id":60643,"date":"2025-01-16T22:06:33","date_gmt":"2025-01-16T21:06:33","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/doximity-to-release-fiscal-2025-third-quarter-results-on-february-6-2025\/"},"modified":"2025-01-16T22:06:33","modified_gmt":"2025-01-16T21:06:33","slug":"doximity-to-release-fiscal-2025-third-quarter-results-on-february-6-2025","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/doximity-to-release-fiscal-2025-third-quarter-results-on-february-6-2025\/","title":{"rendered":"Doximity to Release Fiscal 2025 Third Quarter Results on February 6, 2025"},"content":{"rendered":"
\n

SAN FRANCISCO–(BUSINESS WIRE)–Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal third quarter ended December 31, 2024 after market close on February 6, 2025. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results.<\/p>\n

<\/a>
<\/a><\/p>\n

\nTo listen to a live audio webcast, please visit the Company\u2019s Investor Relations page at https:\/\/investors.doximity.com\/<\/a> before the call. A webcast replay will be available on the website following the call.<\/p>\n

\nAbout Doximity<\/b><\/p>\n

\nFounded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company’s network members include more than 80% of U.S. physicians across all specialties and practice areas. Doximity provides its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. Doximity’s mission is to help doctors be more productive so they can provide better care for their patients.<\/p>\n

Contacts<\/b> <\/p>\n

\nFor investors:<\/b>
Perry Gold
\n
ir@doximity.com<\/a><\/p>\n

\nFor media:<\/b>
Amanda Cox
\n
pr@doximity.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

SAN FRANCISCO–(BUSINESS WIRE)–Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal third quarter ended December 31, 2024 after market close on February 6, 2025. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-60643","6":"format-standard","7":"category-industry"},"yoast_head":"\nDoximity to Release Fiscal 2025 Third Quarter Results on February 6, 2025 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/doximity-to-release-fiscal-2025-third-quarter-results-on-february-6-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Doximity to Release Fiscal 2025 Third Quarter Results on February 6, 2025 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"SAN FRANCISCO–(BUSINESS WIRE)–Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal third quarter ended December 31, 2024 after market close on February 6, 2025. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/doximity-to-release-fiscal-2025-third-quarter-results-on-february-6-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-16T21:06:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20250116860439\/en\/2355675\/22\/dox-logotype-black-rgb_copy.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/doximity-to-release-fiscal-2025-third-quarter-results-on-february-6-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/doximity-to-release-fiscal-2025-third-quarter-results-on-february-6-2025\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Doximity to Release Fiscal 2025 Third Quarter Results on February 6, 2025\",\"datePublished\":\"2025-01-16T21:06:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/doximity-to-release-fiscal-2025-third-quarter-results-on-february-6-2025\\\/\"},\"wordCount\":212,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/doximity-to-release-fiscal-2025-third-quarter-results-on-february-6-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250116860439\\\/en\\\/2355675\\\/22\\\/dox-logotype-black-rgb_copy.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/doximity-to-release-fiscal-2025-third-quarter-results-on-february-6-2025\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/doximity-to-release-fiscal-2025-third-quarter-results-on-february-6-2025\\\/\",\"name\":\"Doximity to Release Fiscal 2025 Third Quarter Results on February 6, 2025 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/doximity-to-release-fiscal-2025-third-quarter-results-on-february-6-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/doximity-to-release-fiscal-2025-third-quarter-results-on-february-6-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250116860439\\\/en\\\/2355675\\\/22\\\/dox-logotype-black-rgb_copy.jpg\",\"datePublished\":\"2025-01-16T21:06:33+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/doximity-to-release-fiscal-2025-third-quarter-results-on-february-6-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/doximity-to-release-fiscal-2025-third-quarter-results-on-february-6-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/doximity-to-release-fiscal-2025-third-quarter-results-on-february-6-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250116860439\\\/en\\\/2355675\\\/22\\\/dox-logotype-black-rgb_copy.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250116860439\\\/en\\\/2355675\\\/22\\\/dox-logotype-black-rgb_copy.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/doximity-to-release-fiscal-2025-third-quarter-results-on-february-6-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Doximity to Release Fiscal 2025 Third Quarter Results on February 6, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Doximity to Release Fiscal 2025 Third Quarter Results on February 6, 2025 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/doximity-to-release-fiscal-2025-third-quarter-results-on-february-6-2025\/","og_locale":"en_US","og_type":"article","og_title":"Doximity to Release Fiscal 2025 Third Quarter Results on February 6, 2025 - Pharma Trend","og_description":"SAN FRANCISCO–(BUSINESS WIRE)–Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal third quarter ended December 31, 2024 after market close on February 6, 2025. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/doximity-to-release-fiscal-2025-third-quarter-results-on-february-6-2025\/","og_site_name":"Pharma Trend","article_published_time":"2025-01-16T21:06:33+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20250116860439\/en\/2355675\/22\/dox-logotype-black-rgb_copy.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/doximity-to-release-fiscal-2025-third-quarter-results-on-february-6-2025\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/doximity-to-release-fiscal-2025-third-quarter-results-on-february-6-2025\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Doximity to Release Fiscal 2025 Third Quarter Results on February 6, 2025","datePublished":"2025-01-16T21:06:33+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/doximity-to-release-fiscal-2025-third-quarter-results-on-february-6-2025\/"},"wordCount":212,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/doximity-to-release-fiscal-2025-third-quarter-results-on-february-6-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250116860439\/en\/2355675\/22\/dox-logotype-black-rgb_copy.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/doximity-to-release-fiscal-2025-third-quarter-results-on-february-6-2025\/","url":"https:\/\/pharma-trend.com\/en\/doximity-to-release-fiscal-2025-third-quarter-results-on-february-6-2025\/","name":"Doximity to Release Fiscal 2025 Third Quarter Results on February 6, 2025 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/doximity-to-release-fiscal-2025-third-quarter-results-on-february-6-2025\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/doximity-to-release-fiscal-2025-third-quarter-results-on-february-6-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250116860439\/en\/2355675\/22\/dox-logotype-black-rgb_copy.jpg","datePublished":"2025-01-16T21:06:33+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/doximity-to-release-fiscal-2025-third-quarter-results-on-february-6-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/doximity-to-release-fiscal-2025-third-quarter-results-on-february-6-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/doximity-to-release-fiscal-2025-third-quarter-results-on-february-6-2025\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20250116860439\/en\/2355675\/22\/dox-logotype-black-rgb_copy.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20250116860439\/en\/2355675\/22\/dox-logotype-black-rgb_copy.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/doximity-to-release-fiscal-2025-third-quarter-results-on-february-6-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Doximity to Release Fiscal 2025 Third Quarter Results on February 6, 2025"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/60643","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=60643"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/60643\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=60643"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=60643"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=60643"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}